Home/Publication/Qiming et al to Boost Cancer Drug Development
Qiming et al to Boost Cancer Drug Development 

12 Jan 2026

US$ 20.00

Qiming Venture Partners (Qiming) has co-led the US$70 m series C1 financing round of Oricell Therapeutics Holdings ......

Price / article: US$20.00
OR existing subscriber
Related Publications

Seraya Partners (Seraya) has acquired a controlling stake in G&B Infratech Co Ltd (G&B) via a US$250 m equity ......

Advent has opened its office in Japan after having retreated from this market in 2011. It named Mr Tomohide Handa as ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.